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Millifluidic culture improves human midbrain
organoid vitality and differentiation†
Emanuel Berger,a Chiara Magliaro, b Nicole Paczia,c Anna S. Monzel,a Paul Antony, d
Carole L. Linster,c Silvia Bolognin,a Arti Ahluwalia b and Jens C. Schwamborn *a
Human midbrain-specific organoids (hMOs) serve as an experimental in vitro model for studying the patho-
genesis of Parkinson's disease (PD). In hMOs, neuroepithelial stem cells (NESCs) give rise to functional mid-
brain dopaminergic (mDA) neurons that are selectively degenerating during PD. A limitation of the hMO
model is an under-supply of oxygen and nutrients to the densely packed core region, which leads eventu-
ally to a “dead core”. To reduce this phenomenon, we applied a millifluidic culture system that ensures
media supply by continuous laminar flow. We developed a computational model of oxygen transport and
consumption in order to predict oxygen levels within the hMOs. The modelling predicts higher oxygen
levels in the hMO core region under millifluidic conditions. In agreement with the computational model, a
significantly smaller “dead core” was observed in hMOs cultured in a bioreactor system compared to those
ones kept under conventional shaking conditions. Comparing the necrotic core regions in the organoids
with those obtained from the model allowed an estimation of the critical oxygen concentration necessary
for ensuring cell vitality. Besides the reduced “dead core” size, the differentiation efficiency from NESCs to
mDA neurons was elevated in hMOs exposed to medium flow. Increased differentiation involved a meta-
bolic maturation process that was further developed in the millifluidic culture. Overall, bioreactor condi-
tions that improve hMO quality are worth considering in the context of advanced PD modelling.
Introduction
The marked difference between human (patho-)physiology and
that of common laboratory animals as well as the difficulty of
obtaining human tissue specimens suitable for experimental
purposes underline the urgent need for high-quality human
in vitro models.1,2 In general, the quality of an in vitro model is
evaluated by the degree of accordance with the tissue or organ
of interest on the one hand and its accessibility by biochemical
analysis methods on the other. Over the last few years, the field
of human stem cell technology has advanced from cultures
containing single cell types to approaches that generate com-
plete organ-like tissues containing multiple cell types in defined
spatial orientations. These in vitro “organoids” are derived from
stem cells that self-organize to form structures resembling the
complexity of a layered tissue but are still well accessible by ex-
perimental tools.3 By definition, organoids contain several cell
types in a spatial organization that closely reflects the organ of
interest, including physiological cell–cell interactions. Several
reports have shown that they are able to recapitulate character-
istic functions of the modelled organ,4 such as neuronal activity
in case of the human brain.5,6 Ideally, for applications such as
in vitro disease modelling, drug testing and even cell replace-
ment strategies, an organoid model should be stable for ex-
tended cultivation and manipulation, reproducible and offer
the possibility for patient-specificity.4 Organoids modelling the
human midbrain are of particular interest, since this region is
specifically targeted by neuro-degeneration during Parkinson's
disease (PD). PD, which is the second most common neurode-
generative disease after Alzheimer's disease, is an age associ-
ated progressive neurodegenerative disorder with yet unknown
aetiology.7 It is characterised by the loss of dopamine-
producing neurons in the substantia nigra located in the mid-
brain, which leads to a lack of the neurotransmitter dopamine
in the striatum. Deprivation of dopamine leads to an impair-
ment of basal ganglia function and causes the typical motor-
symptoms such as rigidity, bradykinesia, akinesia and tremor.8
So far, owing to the complexity of the midbrain, very few
organoids modelling brain structures relevant for PD have
been described.5,9–11 Recently, we developed a protocol for
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deriving midbrain specific organoids (hMOs)5 valuable for
PD disease modelling. For generating hMOs, human
neuroepithelial stem cells (NESCs) derived from human in-
duced pluripotent stem cells (hiPSCs) served as a starting pop-
ulation. hMOs contain all neural cell types comprising neu-
rons, astrocytes and oligodendrocytes. A high proportion of the
neuronal population are midbrain dopaminergic (mDA) neu-
rons that show electrophysiological ion-channel activity includ-
ing the typical “pace-maker” activity underlining the functional
proximity of the model in comparison to the human mid-
brain.5 Nevertheless, the hMOs model shows intrinsic limita-
tions. Most importantly, cells in the densely packed core region
are unable to survive and accumulate to form a so-called “ne-
crotic” or “dead” core.5 This has been described in cerebral
brain organoids before.6 It was also observed in cardiac12 and
liver organoids13 and is considered a limiting factor, hindering
translational applications. Regarding brain organoids, different
approaches have been applied to ensure proper medium sup-
ply, namely orbital shaking,11 spinning flasks6 and mini-biore-
actors.10 However, applying fluidic systems (micro- or milli-
fluidic) have not been considered, so far. In case of the hMOs,
we hypothesize that keeping organoids under continuous or-
bital shaking as per published protocols5 might not be suffi-
cient to ensure a proper supply of nutrients and oxygen. There-
fore, to improve the quality of hMOs we investigated the
effects of applying a continuous medium flow during culture.
In this study we used the “Quasi Vivo®” (QV, Kirkstall, UK)
millifluidic system rather than a microfluidic device14 for a
number of reasons. First, following the concept of allometry,
the size of an organoid should range between approximately
0.5 to 2 mm in order to exhibit physiologically scaled metabo-
lism (oxygen consumption).15,16 In addition, millifluidic sys-
tems such as the QV allow the application of relatively high
flow rates ensuring proper nutrient and oxygen supply without
exposing the organoid to a high shear force due to the flow it-
self. This is due to a well-like design in which the medium in-
let and outlet are located in the chamber lid whereas the
organoid is placed a variable distance from the medium in-
let.17,18 Finally, given their high volume to surface ratio, milli-
fluidic systems do not require frequent media changes, thus
organoid manipulation is reduced to a minimum during cul-
ture. Besides various applications in 2D cultures, the QV milli-
fluidic system has been successfully used to culture liver
organoids13,19 and 3D cardiac constructs20 derived from hu-
man (adult) stem cells.
In this study, we established a stable midbrain organoid
culture under millifluidic conditions and compared it to the
state-of-the-art procedure of continuous orbital shaking using
both a computational fluid dynamics (CFD) and an experi-
mental approach. The CFD analysis was performed to deter-
mine if differences in calculated oxygen profiles in the two
experimental set-ups could be used to explain any of the ob-
served differences in organoids cultured in the two condi-
tions. This comparison revealed improvements in the culture
quality comprising a reduced “dead core”, corroborated by
the models, and increased dopaminergic differentiation.
Material and methods
NESC maintenance, MO generation and cultivation
Human neuroepithelial stem cell (NESC) lines K7 WT (ID
number 3.0.0.10.0), T12.9 WT (3.0.0.14.0) and 34769 WT
(3.0.0.24.1) from three female healthy individuals (81, 53 and
68 years of age) were derived from human iPSC lines as de-
scribed before.21 NESC lines were cultured on GelTrex
(Thermo Fischer Scientific) coated plates. The culture me-
dium (N2B27 maintenance medium) consisted of DMEM-F12
(Invitrogen) and Neurobasal (Invitrogen) media (50 : 50 mix-
ture) supplemented with 1 : 200 N2 supplement (Invitrogen),
1 : 100 B27 supplement lacking vitamin A (Invitrogen), 1% L-
glutamine, 1% penicillin/streptomycin (Invitrogen), 3 μM
CHIR-99021 (Axon Medchem), 0.75 μM purmorphamine
(Enzo Life Science) and 150 μM ascorbic acid (Sigma).21
As described in our original hMO generation protocol,5 on
day 0 of the hMO culture, hNESCs at passage <24 were treated
with accutase (Invitrogen) for 5 min at 37 °C, followed by gentle
pipetting to generate single cells. 9000 cells were seeded into
each well of an ultra-low attachment 96-well round bottom
plate (Corning) and cultured in N2B27 maintenance media to
form 3D NESC-colonies. The medium was changed every other
day. On day 8 of culture, the 3D colonies were transferred to
droplets of LDEV-free and growth factor reduced GelTrex
(Thermo Fisher BD Bioscience) as previously described.22 Drop-
lets were cultured in N2B27 maintenance media in ultra-low at-
tachment 24-well plates (Corning) with one droplet per well for
long-term cultures. On day 10, differentiation was initiated with
N2B27 media supplemented with 10 ng ml−1 hBDNF
(Peprotech), 10 ng ml−1 hGDNF (Peprotech), 500 μM dbcAMP
(Peprotech), 200 μM ascorbic acid (Sigma), 1 ng ml−1 TGF-β3
(Peprotech) and 1 μM purmorphamine (Enzo Life Science). On
this day, one half of the droplets were transferred into Quasi
Vivo® 900 tray (Kirkstall, UK), with one droplet per chamber.
Each chamber contained a nylon-plug at the bottom to reduce
the chamber volume from 4 to 2 mL and to lift the hMO closer
to the medium inlet. For more details regarding the experimen-
tal setup, see Fig. 2A. The medium flow was set to 240 μL
min−1 using a peristaltic flow (PF) 600 cell culture tray pump
(Parker, UK), which is high enough to allow nutrient turnover
without generating turbulence – as per manufacturer's instruc-
tions. Trays and pump were placed into an incubator (5% CO2,
37 °C). The rest of the droplets stayed in 24-well ultra-low at-
tachment 24-well plates with 600 μL of medium per well. To
avoid a dropout of the hMOs from the matrix embedding due
to agitation, the hMO containing 24-well plates were placed on
an orbital shaker (IKA), rotating at 80 rpm, in an incubator (5%
CO2, 37 °C) not before day 14. On day 16, the smoothened-
agonist purmorphamine was removed by media change in both
systems. Shaking organoids were kept in culture with media
changes every second or third day. For QV cultures, after day
16, the medium in the reservoir bottle was changed every 7th
day. Organoids were fixed on day 30 of differentiation in PBS
buffered 4% paraformaldehyde overnight at RT and washed 3×
with PBS for 1 h.
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All experiments with human stem cell lines were done
only with lines were prior patient consent have been
obtained. All these experiments were done in agreement with
the relevant laws and followed the institutional guidelines.
Approval for work with human stem cells has been obtained
by the Ethics Review Panel (ERP) of the University of Luxem-
bourg and by the Luxembourgish Comité National d'Ethique
de Recherche (CNER).
Organoid sectioning, immunofluorescence staining and
imaging
To measure the size of hMOS after fixation, brightfield im-
ages of six organoids per cell line and culture condition were
taken with a stereomicroscope SMZ25 (Nikon) and the hMO
area was measured using the NIS imaging software (Nikon).
For immunofluorescence staining of organoid sections,
fixed hMOs were embedded in 3% low-melting point agarose
(Biozym) in PBS. hMOs were incubated in agarose for 15 min
at 37 °C, followed by 30 min incubation at RT. Sections (50 μm
thickness) was cut using a vibratome (Leica VT1000s) and
centre-sections (middle position between first and last section)
were used for assessing dead core size and TH/FOXA2/TUJ1 ex-
pression. For immune-stainings, sections were permeabilized
with 0.5% Triton X-100 in PBS. Permeabilization times varied
between 30 min and 2 h depending on the antibody used.
Unspecific antigen blocking for 2 h in 2.5% normal donkey se-
rum and 2.5% BSA, 0.1% Triton X-100 and 0.1% sodium azide
was followed by primary antibody incubation for 48 h at 4 °C
on a shaker. Antibodies were diluted in blocking buffer as fol-
lows: rabbit anti-TH (1 : 1000, Abcam), mouse anti-FOXA2 (1 :
250, Santa Cruz Biotechnology), chicken anti-TUJ1 (1 : 600 Milli-
pore), goat anti-SOX2 (1 : 200, R&D Systems) and rabbit anti-
CC3 (1 : 200, Cell Signalling). After incubation with the primary
antibodies, sections were washed three times in PBS containing
0.01% Triton X-100 and blocked for 30 min at RT on a shaker,
followed by incubation with the secondary antibodies diluted
in PBS containing 0.01% Triton X-100 and Hoechst-33 342 nu-
clear dye (1 : 1000; Sigma-Aldrich). All secondary antibodies
(Invitrogen) were conjugated to Alexa Fluor fluorochromes. Sec-
tions were mounted in Fluoromount-G mounting medium
(Southern Biotech) and analysed with a confocal laser scanning
microscope (Zeiss LSM 710).
Image quantification
Based on the Hoechst staining of nuclei in hMO centre sec-
tions, the area of the dead core and the area of the entire sec-
tion was measured using the ZEN Software (Zeiss). Borders of
the dead core area were assessed my means of zoomed-in
views of the corresponding sections (see Fig. S1†).
The immunofluorescence images of hMOs were analysed
in Matlab (Version 2017a, Mathworks). The in-house devel-
oped image analysis algorithms automated the segmentation
of nuclei (Hoechst), neurons (TUJ1), dopaminergic neurons
(FOXA2 and TH) and proliferating cells (SOX2) with sub se-
quential feature extraction. The nuclear segmentation was
computed by convolving a foreground image of the raw
Hoechst channel with a Gaussian filter of size 21 and stan-
dard deviation 1. For the background image, a Gaussian filter
of size 21 and standard deviation of size 3 was used. The dif-
ference was computed by subtracting the background from
the foreground. For the segmentation of neurons, a median
filter was applied to the raw TUJ1 and TH channels and the
resulting images were convolved with a Gaussian filter of size
10 and 11 respectively, and standard deviation 1. TUJ1 and
TH masks were defined by those pixels with values larger
than 45 and 20 respectively. For the FOXA2 mask, a median
filter was applied and all connected components smaller
than 50 were removed. For the SOX2 mask, a median filter
was applied and all connected components smaller than 40
were removed. The SOX2 and FOXA2 masks were identified
within the nuclear mask of each image. For the dopaminergic
neurons, a perinuclear region in FOXA2 positive neurons was
identified, and the presence of TH staining was evaluated. A
mask corresponding to the TH+ perinuclear area of FOXA2+
neuron was normalized to the perinuclear perimeter (TH/
FOXA2 by nuclear perimeter). The SOX2 mask was normal-
ized to the nuclear mask (SOX2 by nuclear mask).
Flow cytometry
For flow cytometry analysis, six hMOs of each cell line were dis-
sociated to single cells by incubation in DMEM-F12 (Invitrogen)
containing 0.18% Papain (Sigma), 0.04% EDTA (Sigma) and
0.04% L-cystein (Sigma) at 37 °C on an orbital shaker until any
surrounding GelTrex disappeared (2–3 h). hMOs were then
treated with accutase (Invitrogen) for further 2–3 h at 37 °C un-
der continuous shaking. During accutase treatment, hMOs
were firstly triturated with a 1000 μL pipette and eventually
with a 200 μL pipette in order to support the dissociation into
single cells. For intracellular staining, the transcription factor
buffer set (BD Bioscience) was used according to the manufac-
turer's instructions. After fixation, cells were filtered through a
5 mL polystyrene round-bottom tube with cell-strainer cap
(Corning). 500 000 cells per condition were used and split into
two samples. One was incubated with primary antibodies at
the following dilutions: chicken anti-TH (1 : 50, Abcam) mouse
anti-FOXA2 (1 : 300, Santa Cruz Biotechnology) and rabbit anti-
LMX1A (1 : 100, Abcam). To set thresholds, the second sample
was incubated with the following isotype control antibodies:
normal chicken IgY Control (R&D Systems), normal rabbit IgG
control (Santa Cruz Biotechnology), and purified Mouse IgG2a,
κ isotype control (BioLegend). Isotype control antibodies were
used at the same concentration as the detection antibody. All
secondary antibodies (Invitrogen) were conjugated to Alexa
Fluor fluorochromes. Flow cytometry was performed by using
BD LSRFortessa cell analyser and data were analysed and repre-
sented by FlowJo software.
Modelling hMO oxygen transport and consumption
3D computational models for oxygen transport were devel-
oped using the COMSOL Multiphysics 4.3 software (COMSOL
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Fig. 1 Reduced “dead core” size in hMO cultured in the millifluidic device. (Ai) Experimental setup for culturing hMO in the millifluidic device. The
picture shows four QV900® circuits connected to one peristaltic pump. All chambers contain one hMO each. (Aii) Schematic drawing of one
QV900® six-chamber circuit. (Bi) Hoechst staining of nuclei (white) of representative hMO sections derived from three different WT NESC lines
and cultured under fluidic or shaking conditions. Yellow dotted lines indicate the area of the “dead core”, whereas the yellow dashed lines indicate
the area of the entire hMOs (scale bar = 200 μm). (Bii) Quantification of area measurements as ratio of “dead core” area and total hMO area (n = 3
per line and culture condition, *p < 0.05). (Biii) Brightfield images of fixed (unsectioned) hMOs with surrounding halos of matrix (scale bar = 1
mm). (Biv) quantification of hMO area measurements (n = 6 per line and culture condition).
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AB, Stockholm, Sweden). Firstly, we developed a reaction and
diffusion multi-physics model of an organoid cultured in a
24 well-plate. In a second model, oxygen mass transport and
consumption were coupled to fluid dynamics based on the
geometry of the QV system. Given that oxygen consumption
in mammalian cells is governed by Michaelis–Menten kinet-
ics,15 we considered a mean literature value of Km = 3 μM
(ref. 17 and 23) and an iPSC oxygen consumption rate (OCR)
of 7 × 10−18 mol per cell per s), as estimated by.24
Both models were based on the methods described in ref.
19. In particular, each configuration was represented using
three sub-domains: i) a fluid domain, in which no oxygen
Fig. 2 Increased predicted oxygenation of hMO under millifluidic culture conditions. (A) Surface plots of oxygen concentration resulting from the
computational model of a hMO in a 24-well (left) or a millifluidic chamber (right). Oxygen concentration gradients are indicated by colours ranging
from 0.2 mol m−3 (dark red) to 0 mol m−3 (dark blue). (Bi–iii) The computed oxygen concentration along the x- (i), y- (ii) and z- (iii) axis passing
through the centre of a hMO cultured either in the millifluidic system (red line) or in the 24-well (blue line). Straight lines indicate the borders be-
tween the organoid and the surrounding medium. Dashed lines indicate the critical oxygen threshold of 0.04 mol m−3. (C) Tabular comparison of
the modelling-based oxygenation status of hMOs cultured under fluidic or shaking conditions.
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consumption occurs and where both fluid-dynamics and the
oxygen diffusion (D = 3 × 10−9 m2 s−1) and convective trans-
port are solved, ii) the midbrain organoid, modelled as a
solid ellipsoid (1200 × 1200 × 800 μm3), where only oxygen
diffusion and consumption are solved (D = 1 × 10−9 m2 s−1),
and iii) an ellipsoidal shell of GelTrex with a thickness of 1
mm and oxygen diffusion, D = 1 × 10−9 m2 s−1, surrounding
the ellipsoid.25
Oxygen transport and consumption in both the 24-well-
and the fluidic system were assumed to be governed by the
generic advection and diffusion equation in its formulation
for uncompressible fluid.30
The organoids cultured in wells are placed on an orbital
shaker with radius of gyration 1 cm. At the gentle rotation
rate used (80 rpm), the media was not observed to intersect
the base of the well. In these conditions, the free surface level
(h) in a cylindrical well of radius R undergoing rigid rotation
at Ω radians per s as a function of the generic radius r can be
described by:26
where V is the volume of fluid, θ is the angular orientation
(= θ·t), ϕ is the phase lag of the fluid with respect to the
plate and Rg is the radius of gyration.
At the centre of the well, where the organoid is placed,
since r = 0 the height h of fluid simplifies to:
The height at the centre varies between 3.2 and 3.0 mm
over each cycle. Given the small difference in height during a
rotation, we assumed the fluid to be in quasi-static condi-
tions with a mean height of 3.1 mm.
The velocity field resulting from fluid flow convection in
the fluidic system was solved using the Navier–Stokes equa-
tion for Newtonian fluid, setting the inlet velocity to 5 × 10−4
m s−1 (corresponding to 240 μL min−1 inflow). In addition,
since the QV fluidic system is made of PDMS, which is gas
permeable,27 the inward oxygen flux through the bioreactor
walls was modelled according to the expression:19
where pO2 is the ambient oxygen partial pressure (159 mmHg
(ref. 28)), KH,O2 is the Henry's constant for oxygen at 37 °C
(1.32 × 10−3 mol m−3 mmHg−1 (ref. 29)), CO2 the oxygen con-
centration in the bioreactor culture chamber at the liquid-
PDMS interface, Pm is the oxygen permeability in PDMS (3.78
× 10−11 mol mm−2 s−1 mmHg (ref. 27)) and hPDMS the PDMS
thickness (6 mm in the fluidic system). The inward flux was
just applied at the lateral walls of the bioreactor. The parame-
ters and constants used in the CFD model are summarised in
Table 1.
Since the experimental set-up consists of six bioreactors in
series, we also calculated the oxygen concentration at the out-
let of the bioreactor so as to use the value as the input con-
centration for the second chamber, and so on. However, the
outlet concentration was not significantly different from the
inlet. All the boundary conditions are summarized in
Table 2.
Estimation of metabolite consumption- and production rates
within the midbrain organoid
For metabolite measurements, medium samples were taken
from the QV reservoir bottles supplying either K7 WT, T12.9
WT or 34769 WT hMOs at day 23 and 30 of differentiation.
For the shaking approach, medium samples were taken from
individual wells and pooled for each hMO line at day 23 and
30 of differentiation (equals n = 3 medium samples per time
point and culture condition). Extracellular glucose, gluta-
mine, glutamate and lactate levels in cell culture media were
measured using a YSI 2950D chemical analyser (Yellow
Springs Instruments). Quantification was based on authentic
standards. Each sample was analysed in technical triplicates.
Quality controls were analysed after every sixth sample ensur-
ing measurement quality. Sample size and reaction time was
40 μL and 30 seconds for glucose and lactate, 25 μL and 40
seconds for glutamine and glutamate, respectively.
Based on the metabolite concentrations in the culture me-
dium (Ct1), we calculated the metabolite consumption- and
production rates for hMOs under flow or shaking conditions.
Table 1 Variables used for the computational models. NB mol m−3 ≡mM
Parameters Values
Organoid width 1200 μm
Organoid height 800 μm
Mid-brain organoid volume (V) 6.03 × 10−10 m3
Number of cells within the organoid
(#cells)
1.8 × 105 cells
Cell density (ρ)
Thickness of GelTrex coating around
organoid
1 mm
Initial and boundary oxygen concentration
(CO2)
0.2 mol m−3 or mM
Single cell maximum oxygen consumption
rate (OCR)
5.5 × 10−18 mol per cell
s
Henry constant for oxygen (KH,O2) 1.32 × 10
−3 mol m−3
mmHg−1
PDMS thickness (hPDMS) 6 × 10
−3 m
Ambient oxygen partial pressure (pO2) 159 mmHg
Oxygen diffusion in water at 37 °C 3 × 10−9 m2 s−1
Oxygen diffusion in GelTrex and organoid
at 37 °C
10−9 m2 s−1
Michaelis Menten constant (Km) 5 × 10
−3 mol m−3
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According to the supplier's information, fresh organoid me-
dium contains Ct0 = 20.4 mM glucose, 0 mM lactate, 2.0 mM
glutamine and 0.024 mM glutamate. t1 equals the timespan
between two medium refreshments (i.e. 2 days for the multi-
well system and 7 days for QV). The metabolite consumption/
production rates vmet were estimated as:
V is the whole system volume (600 μL for the 24-well and 22
mL for QV) and Ncell is the estimated number of cells within
each system (1.8 × 105 for the 24-well and 1.08 × 106 for the
six QV bioreactors connected in a single circuit).
Statistics
The number of replicates “n” refers to the number of individ-
ual hMO per NESC line and culture condition. Statistical
analysis was performed using the Prism 6 software
(GraphPad). For comparison of shaking and millifluidic cul-
ture conditions in three different WT line-derived hMOs,
t-tests (parametric data) or Mann–Whitney rank rum tests
(non-parametric data) were performed. Regarding immuno-
fluorescence image analysis, pixel ratio values for shaking
conditions were set to 100% and the values for millifluidics
were calculated correspondingly. In this case, statistics were
performed applying a one-sample t-test.
Results
Millifluidics reduce the size of the hMO dead core area
The commercially available millifluidic system QuasiVivo900®
(Kirkstall, UK) was set up as follows: the chambers of a six-
chamber tray were filled with one hMO each. The six lids of the
chamber were connected in a row by tubing and each six-
chamber-tray was connected to one reservoir bottle filled with
22 mL of differentiation medium (Fig. 1Ai+ii). This circuit was
connected to a peristaltic pump to expose each organoid to a
flow rate of 240 μm min−1. This value was chosen after various
preliminary tests (data not shown) and in accordance with liter-
ature values using the QV system for liver organoid cultures.19
Up to four tray-units were connected to one poly-head peristal-
tic pump (Fig. 1A). Thanks to the flow and shared media, the
number of media changes could be reduced from once every 2–
3 days (shaking conditions) to once every 7 days (fluidic).
After 30 days of differentiation, hMOs derived from three
different WT NESC lines (K7 WT, T12.9 WT and 34769 WT)
were fixed and sectioned. Measurements of the dead core
area size in comparison to the overall size of the hMOs re-
vealed a trend towards a reduced dead core size under milli-
fluidic conditions in all three WT lines. This decrease in the
fraction of the necrotic area under fluidic conditions reaches
statistical significance upon averaging of the data for all
three organoids (0.16 ± 0.012 vs. 0.14 ± 0.012, p = 0.017;
Fig. 1Bi+ii; Fig. S1†). Of note, the overall size of the hMOs
was not significantly different after millifluidic cultivation in
comparison to shaking conditions in neither of the WT lines
(Fig. 1Biii+iv). These data indicate that hMO vitality is supe-
rior in millifluidic culture conditions.
Millifluidics show increased oxygenation in a computational
oxygen transport and consumption model
Since oxygen is considered as a limiting nutrient for 3D cell
cultures and under-oxygenation of the organoid contributes
to the appearance of the “dead core”, we assessed the O2 con-
centration profile in the culture medium and inside the
organoids.
Multi-physics 3D models that couple oxygen mass trans-
port and consumption to fluid dynamics were used to predict
oxygen concentration profiles during the 3D culture in both
the 24-well and the QV chamber. Surface plots of steady state
oxygen concentrations of both the 24-well and in the milli-
fluidic chamber are shown in Fig. 2A. The streamline plot of
the computed fluid velocity field shows laminar medium flow
in the chamber (Fig. S2†). Having a closer look at the oxygen
profiles around and inside the hMO along the x-, y- and z-
axis (with origin fixed at the organoid centroid, Fig. 2B) re-
veals that the oxygen concentration is higher in the fluidic
system than in the shaking 24-well plate. As shown in
Fig. 2Biii, the oxygen profile along the vertical (z) axis is not
symmetric with respect to the centroid because the ellipsoi-
dal shape of organoids allows medium to flow and oxygen to
diffuse underneath it. Overall, according to the computa-
tional model, the average oxygen concentrations in the hMO
are similar in the two conditions (Fig. 2C). However, the min-
imal oxygen concentration inside the hMO is considerably
higher under fluidic conditions. To determine the critical via-
ble oxygen concentration, we compared the computed cross-
sectional areas at the centre of the organoids with those
obtained from image processing of Hoechst-stained slices.
Table 2 Boundary conditions used for the oxygen convection and diffusion and for the Navier–Stokes models
Model Surface Boundary condition
Oxygen convection and diffusion Quasi Vivo side walls Inward oxygen flux through PDMS
Interface between the MO and the fluid sub-domain Continuity
Fluid domain inlet Constant oxygen concentration
Fluid domain outlet Convective flux
Navier–stokes Solid–liquid interfaces No slip
Fluid domain inlet Normal inflow velocity
Fluid domain outlet Pressure, no viscous stress
Lab on a Chip Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
Se
pt
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 9
/1
8/
20
18
 1
2:
10
:3
3 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Lab Chip This journal is © The Royal Society of Chemistry 2018
For both fluidic and shaking conditions, the results indicate that
cells below 0.040 ± 0.011 mol m−3 are unlikely to survive in the
core. The computed volume proportion of the hMO lying under
this critical oxygen threshold of 0.04 mol m−3 is smaller in the
Quasi-Vivo (1.8%) compared to shaking conditions (6.4%) indi-
cating that the millifluidic system is more efficient for oxygen
transport compared to the shaking in 24-well plates (Fig. 2C).
Millifluidics increase the proportion of dopaminergic
neurons in a cell line specific manner
Convective transport not only increases oxygen supply but
also exposes the organoids to higher amounts of growth- and
differentiation factors. Since the differentiation process is di-
rected towards mDA neurons, we checked for typical marker
expression of this cell type by immunostaining of fixed hMO
sections after 30 days of differentiation. The combined ex-
pression of tyrosine hydroxylase (TH) and neuron-specific
class III tubulin (TUJ1) identifies the dopaminergic neuronal
lineage and the presence of F-box protein A2 (FOXA2) indi-
cates the midbrain fate (Fig. 3Ai). Computational image anal-
ysis revealed that hMOs kept under fluidic conditions reach
higher proportions of TH+/FOXA2+/TUJ1+ neurons in compari-
son to shaking conditions. Interestingly, this effect was line
dependent. The effect was significant for the 34769 WT line,
whereas there was just a slight increase in mDA
Fig. 3 Line specific increase in mDA differentiation under millifluidic culture conditions. (Ai) Immunofluorescence stainings of representative hMO
sections derived from three different WT NESC lines and cultured under shaking or fluidic conditions (merge of TH, FOXA2, TUJ1 and Hoechst
staining; scale bar = 500 μm). For better comparability of TH quantities, the corresponding TH staining (white) is depicted next to the merge. (Aii)
Mask-based image quantification (pixel ratios) of TH+/FOXA2+ cells in the corresponding immunofluorescence stainings (n = 3 per cell line and cul-
ture condition; *p < 0.05). (Aiii) mean pixel ratio values for TH+/FOXA2+ cells in hMO of three different WT lines under fluidic conditions relative to
those under shaking conditions (set to 100%). (Bi) Flow cytometry analysis (contour plots) of single cells obtained from dissociated hMOs from
three different WT NESC lines and cultured under shaking or fluidic conditions (blue lines = isotype control, red lines = target staining). Percent-
ages of FOXA2+/TH+ cells are indicated in the upper right corner of the plots. (Bii) The bar chart summarizes the percentages of FOXA2+/TH+ cells
presented above. (Biii) Percentage of FOXA2+/TH+ cells in MO under fluidic conditions relative to those ones under shaking conditions (set to
100%).
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differentiation in the K7 WT line. For the T12.9 WT line, no
difference could be detected (Fig. 3Ai+ii). Setting the staining
signal of TH+/FOXA2+/TUJ1+ neurons under shaking condi-
tions to 100% for each line makes the line specific increase
in mDA differentiation under millifluidic conditions even
more apparent (Fig. 3Aiii).
Dopaminergic differentiation is fuelled by neuroepithelial
stem cells that express the sex determining region Y-box 2
(SOX2) among other markers. Immunostaining for SOX2 re-
vealed that a higher degree of mDA differentiation goes along
with a reduced amount of SOX2+ NESCs and vice versa (Fig.
S3i–iii†). This significant effect was still largely cell line de-
pendent and was most apparent in the 34769 line-derived
organoids. Here, hMOs cultured under shaking conditions
maintained a bigger SOX2+ stem cell reservoir compared to
the corresponding hMOs under millifluidic conditions.
To back up our observations based on imaging of
immunostainings, we included a further level of evaluation.
After 30 days of differentiation, hMOs were dissociated to
singe cells, immunostained for TH and FOXA2 and subse-
quently analysed by flow cytometry. This analysis confirmed
the significant increase in mDA neurons for the 34769 WT
line, the trend towards higher proportions in the K7 WT line
as well as the equal levels in the T12.9 WT line under milli-
fluidic conditions (Fig. 3Bi–iii). Flow cytometry analysis of
cells expressing TH and LIM homeobox transcription factor
1A (LMX1A), an additional marker of ventral midbrain speci-
fication, confirmed the quantitative differences between flu-
idic and shaking conditions (Fig. S4i–iii).
During differentiation towards mDA neurons, cells change
their metabolic profile. While stem cells mainly convert glu-
cose into lactate via anaerobic glycolysis to cover their energy
demand, postmitotic neurons undergo a metabolic switch to-
wards mitochondrial respiration.32 Therefore, we measured
the concentration of specific metabolites in the culture me-
dium of organoids after fluidic or shaking culture (Fig. 4A) at
two different time points and calculated the consumption or
production rate per cell. At both time points, hMOs cultured
in millifluidic chambers consume less glucose und secrete
less lactate into the culture medium compared to those ones
under shaking conditions (Fig. 4i+ii). Furthermore, hMOs in
the fluidic device take up significantly more glutamine and
excrete significantly more glutamate (Fig. 4iii+iv). Secreted
glutamate points to the presence of glutamatergic neurons,
which can be considered as a by-product of mDA differentia-
tion. Therefore, the metabolic profiles observed under fluidic
culture conditions support the data obtained by marker ex-
pression indicating an increased differentiation efficiency un-
der these conditions.
Discussion
Over the past years, organoids have been derived from vari-
ous stem cell sources to generate models of various brain re-
gions. The properties of these brain organoid models have
been reviewed recently.33 Apparently, orbital shaking or spin-
ning bioreactors are the predominant culture systems for
brain organoids, with little difference being reported between
the two.34 Despite the fact that describing fluid dynamics ac-
curately in shakers and spinners is extremely difficult due to
the essentially turbulent nature of the flow, systems with a
continuous medium flow have not been considered, so far.
Our data show that human midbrain organoids can be cul-
tured under continuous laminar medium flow and that these
conditions improve the properties of hMO in comparison to
orbital shaking.5 This improvement comprises a reduced size
of the “dead core” area and an increased differentiation to-
wards midbrain dopaminergic neurons.
Whether the “dead core” is of necrotic or apoptotic nature
is difficult to distinguish, since the core region usually
disintegrated during sectioning. However, it should be noted
that under ischemic conditions in the brain e.g. after stroke,
necrotic and apoptotic mechanisms cannot be clearly sepa-
rated.35 Experimental evidence indicates a time dependent
convergence of both mechanisms.36,37 One possible explana-
tion for the appearance of the “dead core” is persistent hyp-
oxia in the core region due to a lack of vasculature. However,
which oxygen concentration can be considered as hypoxic is
a matter of debate. In the human brain, an average oxygen
tension (partial pressure pO2) of above 35 mmHg (equals 0.05
mol m−3 at 37 °C according to Henry's law17) ensures normal
oxygenation of the brain tissue,31 which is considerably less
than the inhaled ambient oxygen tensions of 159 mmHg
(21% of air). A value of 35 mmHg is considered as a “physio-
logical hypoxia” or “in situ normoxia”.38 Our modelling ap-
proach reveals that oxygen concentrations in the centre of
the organoid reach closely or even drop under 0.05 mol m−3.
By overlapping the computed oxygen profiles across the cen-
tre of the organoids with images of necrotic nuclei, we identi-
fied a critical concentration threshold of 0.04 ± 0.011 mol
m−3. In both the images and the models the zone lying under
the threshold is smaller in hMOs cultured under millifluidic
conditions. Besides oxygenation, other limiting factors could
also contribute to the formation of a “dead core”. The diffu-
sion of glucose and other nutrients to the core or the local ac-
cumulation of toxic compounds like acids (lactic acid, car-
bonic acid) and reactive oxygen species that cannot be
removed properly due to the lack of vasculature have to be
considered. Therefore, attempts towards a vascularization of
the hMOs appear crucial for tackling the supply issues in this
model.
Differences in oxygenation might also contribute to the in-
crease in dopaminergic differentiation under millifluidic con-
ditions. In the brain, neural stem cells (NSCs) and especially
the embryonic neural tube are located in an environment
that faces very low oxygen levels. For instance, in the dentate
gyrus of the hippocampus, an area of adult neurogenesis, pO2
levels reach down to 6–8 mmHg.39 During embryonic devel-
opment, the neural tube in both the hindbrain and midbrain
regions is exposed to oxygen levels substantially below 7.6
mmHg.40 Obviously, NSCs seem to be very well adapted to
this environment. In vitro studies have shown that hypoxia is
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able to promote an undifferentiated state in NSCs and neural
crest stem cells.41 In case of our hMO model, the slightly re-
duced oxygenation under shaking conditions might maintain
the stem cells longer in an undifferentiated state and dimin-
ish the differentiation to mDA neurons. Moreover, it is likely
that the exposure of hMOs to a higher volume of medium
and thereby a higher amount of neurotrophic factors in the
millifluidic system contributes to the differentiation process.
However, the effect of elevated dopaminergic differentiation
is dependent on the individual NESC line used for hMO gen-
eration. Obviously, dopaminergic differentiation is following
a saturation curve with a maximum at about 60–75% (at 30
days of differentiation), but the kinetics of this process are
different between the respective NESC lines. This might be
caused by the individual genetic background or differences
in the culture history that the lines were facing. We have
strong evidence, that the genetic background plays an impor-
tant role for the dopaminergic differentiation efficiency in 2D
cultures of NESC derived neurons (unpublished data).
Stem cells are adapted to low oxygen concentrations by
conductingmainly glycolysis to cover their energy demand pro-
ducing lactic acid to recycle their reduction equivalents.
Postmitotic neurons, in contrast, undergo a metabolic switch
towards mitochondrial respiration.32 In this context, the differ-
ent metabolite profiles measured in the culture medium of
shaking and fluidic hMO, adds further evidence for the in-
creased differentiation efficiency that we observed under flow
conditions. Since proliferation is an energy-demanding pro-
cess and glycolysis is less energy efficient than oxidative phos-
phorylation, a higher proportion of NESC leads to higher glu-
cose consumption and higher lactic acid levels in the medium
as we see under shaking conditions. The switch from anaero-
bic glycolysis to oxidative phosphorylation also enables the
conversion of glutamine into glutamate using the tricarboxylic
acid cycle. Therefore, lower glutamine uptake and higher gluta-
mate release can be a sign of increased differentiation as we
see under millifluidic conditions. Recent data from our group
show that besides the majority of mDA neurons also
glutamatergic and GABAergic neurons arise from NESC in
hMOs (unpublished data). Interestingly, the differences onme-
tabolite levels are less cell-line dependent than the marker ex-
pression analysis mentioned before. This might be explained
by the fact that the cell culture medium represents the average
effect over a certain time period, whereas the marker analysis
is a snapshot of the current cellular status within the hMO.
Currently, we are working on a method to assess the release of
the neurotransmitter dopamine by matrix-embedded hMOs as
a direct measure of the differentiation efficiency.
Overall, our millifluidic approach delivered promising re-
sults regarding the quality of the organoid culture. Neverthe-
less, the throughput of organoids is rather low in the present
system. The next step could be a size adaptation of the
Fig. 4 Shifted metabolite consumption and production in hMOs under fluidic conditions. (A) Schematic drawing of the experimental approach:
measurement of glucose and glutamine uptake from the culture medium as well as lactate and glutamate excretion into the medium. Glucose (Bi)
and glutamine (Bii) consumption as well as lactate (Biii) and glutamate (Biv) secretion rate in mole per cell per day by hMOs cultured in 24-wells or
in QV chambers (n = 3 medium samples per line and culture condition; ***p < 0.001, **p < 0.01, *p < 0.05).
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organoids, within the limitations of allometric scaling, to ad-
vance the system towards a midbrain-on-a-chip approach suit-
able for high-throughput and high-content assays using inte-
grated sensor techniques. This would facilitate the use of
organoids as a tool for Parkinson's disease modelling and
personalized therapeutic screening.
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